Conrad-Amadeus Voltin

9PUBLICATIONS
26CO-AUTHORS
Gene and molecular therapyInnate immunityHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Education assessment and evaluation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 27, 2026
Rapid molecular response kinetics to anti-PD-1-based first-line treatment of Hodgkin lymphoma in the GHSG NIVAHL trial.

Jan-Michel Heger, Julia Mattlener, Peter Herhaus

|Aug 27, 2025
Serum TARC dynamics during anti-PD1-based first-line Hodgkin lymphoma treatment: An analysis from the GHSG NIVAHL trial.

Wouter J Plattel, Sophie Teesink, Lydia Visser

|Feb 05, 2024
Long-term remission in a patient with relapsed Richter's transformation treated with CD19-directed chimeric antigen-receptor T-cells after allogeneic stem cell transplantation.

Nadine Kutsch, Philipp Gödel, Conrad-Amadeus Voltin

|Dec 19, 2023
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy.

Conrad-Amadeus Voltin, Andrea Paccagnella, Michael Winkelmann

|Sep 09, 2023
How to attract young talent to nuclear medicine step 1: a survey conducted by the EANM Oncology and Theranostics Committee to understand the expectations of the next generation.

Valentina Ambrosini, Sofia Carrilho Vaz, Niloefar Ahmadi Bidakhvidi

|Feb 25, 2022
Influences on PET Quantification and Interpretation.

Julian M M Rogasch, Frank Hofheinz, Lutz van Heek

Pageof 2

Frequent Collaborators

2 joint publications

Bastian von Tresckow

2 joint publications

Paul J Bröckelmann

2 joint publications

Carsten Kobe

1 joint publications

Christian Baues